The DOI matches its Crossref record; 229 of the 229 references it cites were found in a registry or an index.
Metabolism of immune cells in cancer
Open accessAbstract
Through the successes of checkpoint blockade and adoptive cellular therapy, immunotherapy has become an established treatment modality for cancer. Cellular metabolism has emerged as a critical determinant of the viability and function of both cancer cells and immune cells. In order to sustain prodigious anabolic needs, tumours employ a specialized metabolism that differs from untransformed somatic cells. This metabolism leads to a tumour microenvironment that is commonly acidic, hypoxic and/or depleted of critical nutrients required by immune cells. In this context, tumour metabolism itself is a checkpoint that can limit immune-mediated tumour destruction. Because our understanding of immune cell metabolism and cancer metabolism has grown significantly in the past decade, we are on the cusp of being able to unravel the interaction of cancer cell metabolism and immune metabolism in therapeutically meaningful ways. Although there are metabolic processes that are seemingly fundamental to both cancer and responding immune cells, metabolic heterogeneity and plasticity may serve to distinguish the two. As such, understanding the differential metabolic requirements of the diverse cells that comprise an immune response to cancer offers an opportunity to selectively regulate immune cell function. Such a nuanced evaluation of cancer and immune metabolism can uncover metabolic vulnerabilities and therapeutic windows upon which to intervene for enhanced immunotherapy. This Review discusses our current understanding of adaptive and innate immune cell metabolism in the context of the tumour microenvironment, providing insight into the interaction of cancer cell metabolism and immune metabolism, as well as the potential for leveraging metabolic vulnerabilities to enhance the antitumour immune response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Similarly, HIF-2α directly upregulates PD-L1 expression by binding to the HRE in the PD-L1 promoter in ccRCC cells (Fig. 2C) [73].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [73]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: mTORC1-Induced HK1-Dependent Glycolysis Regulates NLRP3 Inflammasome Activation
Moon, J.-S., Hisata, S., Park, M. A., DeNicola, G. M., Ryter, S. W., Nakahira, K., & Choi, A. M. K. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.05.046 · Cited by 379
Retracted5-Fluorouracil: mechanisms of action and clinical strategies
Longley, D. B., Harkin, D. P., & Johnston, P. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1074 · Cited by 5,332
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Succinate is an inflammatory signal that induces IL-1β through HIF-1α
Tannahill, G. M., Curtis, A. M., Adamik, J., Palsson-McDermott, E. M., McGettrick, A. F., Goel, G., Frezza, C., Bernard, N. J., Kelly, B., Foley, N. H., et al. (2013) · Nature · doi:10.1038/nature11986 · Cited by 4,176
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, C.-H., Qiu, J., O’Sullivan, D., Buck, M. D., Noguchi, T., Curtis, J. D., Chen, Q., Gindin, M., Gubin, M. M., van der Windt, G. J. W., et al. (2015) · Cell · doi:10.1016/j.cell.2015.08.016 · Cited by 3,331
Functional Polarization of Tumour-Associated Macrophages by Tumour-Derived Lactic Acid
Colegio, O. R., Chu, N.-Q., Szabo, A. L., Chu, T., Rhebergen, A. M., Jairam, V., Cyrus, N., Brokowski, C. E., Eisenbarth, S. C., Phillips, G. M., et al. (2014) · Nature · doi:10.1038/nature13490 · Cited by 3,046
Mitochondrial TCA cycle metabolites control physiology and disease
Martínez-Reyes, I., & Chandel, N. S. (2020) · Nature Communications · doi:10.1038/s41467-019-13668-3 · Cited by 2,813
Physiological Roles of Mitochondrial Reactive Oxygen Species
Sena, L. A., & Chandel, N. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.09.025 · Cited by 2,632
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I. E., Conway, S. J., Marshall, B., Brown, C. C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,589
Cited by
Sorted by citations
Items 601–700 of 899
Promising Therapeutic Approach in Pancreatic Cancer: Metabolism-Related Genes
Choe, S., Kwak, W., Kim, E., Shin, S., Shin, M., Koh, H. J., & Yoon, H. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904137 · Cited by 3
Pan, H., Li, C., Wang, M., Kang, Y., Fan, X., Fu, Y., Yang, J., & Li, Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-05890-5 · Cited by 3
Epigenetic Reprogramming of the Glucose Metabolic Pathways by the Chromatin Effectors During Cancer
Mondal, P., Tiwary, N., Sengupta, A., Dhang, S., Roy, S., & Das, C. (2022) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-07634-3_9 · Cited by 3
Meng, J., Deshayes, E., Zhang, L., Shi, W., Zhang, X., Chen, X., Mei, X., Ma, J., Jiang, Y., Wu, J., et al. (2021) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2021.10.008 · Cited by 3
Comprehensive Analysis of Immune Correlation of KIF20A in Pan-cancerPreprint
Cui, X., Peng, Q.-J., Gao, P., Zhang, X., Li, R., Zhu, B., Zhou, Z., Zhu, C., & Qin, X. (2020) · Research Square · doi:10.21203/rs.3.rs-127486/v1 · Cited by 3
He, J., Chen, Z., Xue, Q., Sun, P., Wang, Y., Zhu, C., & Shi, W. (2022) · Research Square · doi:10.21203/rs.3.rs-1334726/v1 · Cited by 3
Zhang, Q., Liu, N., Wu, D., Xu, Z., Wang, Y., & Wang, P. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.22.497145 · Cited by 3
Li, C., Qin, C., Li, X., Wang, J., Li, Y., & Sun, Q. (2026) · International Journal of Oncology · doi:10.3892/ijo.2026.5845 · Cited by 3
Sun, Y., Shi, G., Yang, J., Zhou, C.-Z., Peng, C., Luo, Y., Pan, Y., & Wang, R. L. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1495280 · Cited by 2
Zhang, H., Zhang, Z., Li, L., Gao, S., Jia, F., Ma, J., Liu, M., Yang, M., Sun, R., Li, H., et al. (2025) · Annals of Hematology · doi:10.1007/s00277-025-06410-1 · Cited by 2
Tiwary, S., Hsu, K. S., Goldfarbmuren, K. C., Xia, Z., & Berzofsky, J. A. (2025) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-24-0927 · Cited by 2
Engineering glutamine-regulating nanomedicines for efficient tumor therapy
Hou, G., Lu, S., Chen, Y., Lei, H., Yi, B., & Cheng, L. (2025) · Materials Today · doi:10.1016/j.mattod.2025.09.019 · Cited by 2
Lu, X., Qiang, M., Li, R., Guo, C., Li, K., Yao, Y., Wang, J., Wang, C., Tu, K., Chen, Y., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07056-3 · Cited by 4
Ye, Q., Zhong, D., Wang, D., Zhang, X., Wang, R., Hu, H., Li, D. D., Wang, K., Zhu, N., Shi, S., et al. (2025) · Advanced Functional Materials · doi:10.1002/adfm.202519503 · Cited by 2
Tian, S., Liu, Y., Yang, H., Chen, K., Li, J., Chen, L., Wu, T., & Zhang, L. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s548338 · Cited by 2
He, J. N., Gao, Y., Sun, Z. S., Li, Y., Wang, J., Zhang, L., & Liu, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1686071 · Cited by 2
A Double-Edged Role for SIRT7 in Cancer: Can Anti-Cancer Immunity Tip the Balance?
Tarighi, S., Ning, Z., Gámez-García, A., Vaquero, A., Braun, T. W., & Ianni, A. (2025) · Pharmaceuticals · doi:10.3390/ph18121878 · Cited by 2
Zhang, F., Dong, C., Chow, R. D.-W., Xin, S., He, E., Feng, Y., Zhu, L., Mirza, D., Tian, X., Yang, L., et al. (2026) · Cancer Discovery · doi:10.1158/2159-8290.cd-25-0545 · Cited by 2
Zu, P., & Yu, Z. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1761070 · Cited by 2
Nanovaccines for lung cancer: Platforms, mechanistic insights, and translational challenges
Hosseinalizadeh, H., Ge, F., Davari, M., Liu, X., Tian, L., & Yu, J. (2026) · Chinese Medical Journal - Pulmonary and Critical Care Medicine · doi:10.1016/j.pccm.2026.02.001 · Cited by 2
Suramin Interactions Across Biological Systems: From Molecular Targets to Therapeutic Implications
Catalano, A. A., Scaglione, V., Sgobba, M. N., Ferrone, L., Francavilla, A. L., Cavalluzzi, M. M., Todisco, S., Guerra, L., Volpicella, M., Grassi, A., et al. (2026) · Biomolecules · doi:10.3390/biom16040527 · Cited by 2
Pan, Y., Hu, X., & Cheng, J. (2026) · Discover Oncology · doi:10.1007/s12672-026-05070-5 · Cited by 2
Metabolic pattern changes of macrophages during cancer development and progression
Liu, G., Wang, B., Wang, S., Shi, L., Han, H., & An, T. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08210-1 · Cited by 2
Cheng, H., & Wong, C. C. (2026) · Molecular Cancer · doi:10.1186/s12943-026-02698-3 · Cited by 2
Lim, G., Kim, J., Park, D., Lee, J. H., Roh, Y. J., Yang, M., Lee, S., Yang, S., Baek, S., Park, J., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117412 · Cited by 3
Zhao, Y. F., Zhang, D., & Sun, Y. (2022) · Journal of Oncology · doi:10.1155/2022/7248572 · Cited by 2
Indoleamine 2,3-Dioxygenase (IDO) and Cancerous Cells
Safdarian, A. R., Farhangnia, P., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_72-1 · Cited by 2
Zhang, Y., Liu, C., Ju, H., Jia, R., Gao, S., Liu, X., Menéndez‐Arias, L., & Zhan, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18611-0.00028-0 · Cited by 3
Zheng, J., Wang, Y., Fang, X., & Hu, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-42209-8 · Cited by 2
Zeng, J., Zhu, P., Tang, Y., Zhang, C., Ye, C., Cheng, S., Tian, K., Yang, B., Zeng, W., Liu, Y., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-43023-y · Cited by 2
Bao, J., & Yu, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1241677 · Cited by 2
Yu, D., Zhang, J., Li, X., Xiao, S., Xing, J., & Li, J. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1308754 · Cited by 2
Xie, K., Chen, Z., Feng, J., Pan, L., Wang, N., Luo, J., Yao, Y., Ma, H., Feng, Y. Y., & Jiang, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1344317 · Cited by 2
Prognostic Signature in Osteosarcoma Based on Amino Acid Metabolism-Associated Genes
Feng, L., Chen, Y., Mei, X., Wang, L., Zhao, W., & Yao, J. (2024) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2024.0002 · Cited by 2
Mitochondrial metallopeptidase OMA1 in cancer
Purohit, G., Ghosh, P., & Khalimonchuk, O. (2024) · Advances in cancer research · doi:10.1016/bs.acr.2024.05.001 · Cited by 3
Immune check point inhibitors in BRAF mutated metastatic colorectal cancer: A review
Colombo, A., Cordio, S. S., & Porretto, C. M. (2024) · International Journal of Gastrointestinal Intervention · doi:10.18528/ijgii240030 · Cited by 2
ZHUO, R., Huang, H., la Roche, L. A. T.-D., Wilde, R. L. D., Wang, G., ZENG, D., Wang, W., Kahlert, U. D., & Shi, W. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.054642 · Cited by 2
Feng, G., Wang, D., Li, B., Wang, S., Hao, Y., Zhou, X., Qian, N., Meng, Q., Cao, J.-M., Zheng, B., et al. (2025) · Chemical Engineering Journal · doi:10.1016/j.cej.2025.161011 · Cited by 2
Zang, Z., Xu, Y., Duan, C., Yuan, Y., Shen, Y., Wu, J., Lei, Z., & Li, S. Z. (2025) · Information Fusion · doi:10.1016/j.inffus.2025.103108 · Cited by 4
From COPD to cancer: indacaterol’s unexpected role in combating NSCLC
Liu, C., Huang, J., Cai, P., Jiang, M., & Chen, H. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1579126 · Cited by 2
Ni, P., Li, L., Du, K., Nov, P., Wang, D., Wang, C., Kou, Q., Li, Y., Zhang, Y., Zheng, C., et al. (2025) · Discover Oncology · doi:10.1007/s12672-025-02250-7 · Cited by 2
Tumor immune evasion and the Let-7 family: insights into mechanisms and therapies
Allela, O. Q. B., Al-Hussainy, A. F., Sanghvi, G. V., Roopashree, R., Kashyap, A., Anand, D. A., Panigrahi, R., Маратовна, Г. Л., Taher, S. G., Alwan, M., et al. (2025) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-025-04283-9 · Cited by 2
Nguyen, M. H., Ta, H. D. K., Nguyen, D. P. Q., Le, V. H., & Le, N. Q. K. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47070552 · Cited by 2
Wang, Y., Cao, F., Huang, M., Teng, Q., Guan, Y., & Pang, J. (2025) · The FASEB Journal · doi:10.1096/fj.202501308rr · Cited by 2
Proteomics and Protein Biomarkers in Cancer Metastasis
Gezici, S. (2025) · Springer eBooks · doi:10.1007/978-3-032-00763-6_150 · Cited by 2
Stimulated Raman scattering imaging of cancer metabolism: New avenue to precision medicine
Yue, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85158-9.00027-0 · Cited by 2
Cellular metabolism and diseases
Maiuri, M. C., & Maffia, P. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15355 · Cited by 2
Metabolic reprogramming and immunity in cancer
Chen, Y., & Li, Y. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823397-9.00006-5 · Cited by 2
Secondary prevention of gastric cancer and Traditional Chinese Medicine countermeasures
Tang, X., Liu, L., Wang, F., & Wang, P. (2022) · Scientia Sinica Vitae · doi:10.1360/ssv-2021-0396 · Cited by 2
Telomerase-activated Au@DNA nanomachine for targeted chemo-photodynamic synergistic therapy
Zhou, Y., Zhang, J., Cao, D., Tang, A., & Kong, D. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00379e · Cited by 2
Ma, S., Wu, X., Wu, Z., & Zhao, Q. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2269788 · Cited by 2
Transcriptomic Profiling of Pleural Effusions: Differences in Malignant and Infectious Fluids
Zamora-Molina, L., García-Pachón, E., Amorós, M., Gijón-Martínez, J., Sánchez-Almendro, J., Baeza-Martínez, C., Blasco, L., & Galiana, A. (2024) · Medicina · doi:10.3390/medicina60030424 · Cited by 2
Liu, X., Zhao, Y., Wu, X., Liu, Z., & Liu, X. (2022) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pacr2ed.2.22.25 · Cited by 2
Editorial overview: Cancer Immunotherapy: Are we there yet?
Ohashi, P. S., & Sharpe, A. H. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.04.008 · Cited by 2
Kim, S., Koh, J., Song, S. G., Yim, J., Kim, M., Keam, B., Kim, Y. T., Kim, J., Chung, D. H., & Jeon, Y. K. (2022) · Research Square · doi:10.21203/rs.3.rs-1357368/v1 · Cited by 2
Post-transcriptional regulator HuR promotes immune evasion in pancreatic ductal adenocarcinomaPreprint
Guo, Y., Finan, J. M., Bartlett, A. Q., Sivagnanam, S., Blise, K. E., Kirchberger, N. C., Betre, K., McCarthy, G. A., Hawthorne, K., Chen, C., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.07.632847 · Cited by 2
C-myc modulates the replication of RGNNV via glutamine-mediated ATP production in grouper fin cells
Yao, M., Chen, H., Tao, J., Wei, L., Tang, Y., Lin, J., Shi, F., Zhan, F., Li, Y., Li, J., et al. (2023) · Aquaculture and Fisheries · doi:10.1016/j.aaf.2023.05.005 · Cited by 1
Yu, Q., Tian, L., Su, W., Li, X., Wang, J., Guo, L., Huang, L., & Gao, W. (2023) · ACS Materials Letters · doi:10.1021/acsmaterialslett.3c01027 · Cited by 1
Advanced nanotherapeutics inspired by the abnormal microenvironment of leukemia
Zhang, H., Liu, T., Liu, M., Wang, S., Huang, Y., Ma, Y., Sun, B., He, Z., & Sun, J. (2024) · Nano Research · doi:10.1007/s12274-024-6838-4 · Cited by 1
Recent process of using nanoparticles in the T cell-based immunometabolic therapy
Chen, B., Li, Y. Y., & Wang, H. (2024) · Nanotechnology Reviews · doi:10.1515/ntrev-2024-0072 · Cited by 1
Vanisree, A. J., Thamizhoviya, G., & Thiruvalluvan, A. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04538-1 · Cited by 1
Shi, D., Liu, L., Qin, K., Zheng, Y., Hu, W., You, J., Wu, P., 郝新忠, Liu, H., Gao, J., et al. (2025) · Molecular Imaging and Biology · doi:10.1007/s11307-025-02024-1 · Cited by 1
Lai, Z., Hu, C., Jie, J., Xiao, Y., Zhu, Y., Guo, X., Liu, Y., Wang, Y., Pang, S., Zeng, X., et al. (2025) · Cancer Pathogenesis and Therapy · doi:10.1016/j.cpt.2025.06.008 · Cited by 1
Du, T., Zha, X., Zhang, Y., & Huang, Q. M. (2025) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2025.100980 · Cited by 1
Fu, C., Bian, C., Zhu, W., Du, H., Han, L., Zhu, J. K., Wang, J., & Cao, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1637165 · Cited by 1
Zhou, W., Ding, J., Shen, Y., Huang, F., & Xu, D. (2025) · Medicine · doi:10.1097/md.0000000000044282 · Cited by 1
Targeting autophagy and metabolism for ewing sarcoma
Antoshina, K., Aniskin, D., Stempen, M., Schroeder, B., Timashev, P. S., Ulasov, I. V., Chaudhary, A., & Kharwar, R. K. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11304-6 · Cited by 1
Multimodal learning for scalable representation of high-dimensional medical data
Alsaafin, A., Shafique, A., Alfasly, S., Kalari, K. R., & Tizhoosh, H. R. (2026) · Frontiers in Digital Health · doi:10.3389/fdgth.2025.1709277 · Cited by 1
Hu, G., Li, H., Su, R., Han, L., Wang, T., & Yu, H. (2026) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2026.108994 · Cited by 1
Yu, S., Li, X., Wu, J., Wang, M., Gong, Z., Zhang, B., Shi, H., Wang, X., & Xiang, W. (2026) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.71054 · Cited by 1
Li, Y., Qian, T., Han, Z., Wang, C., Zhang, M. X., Huang, C., Gu, Q., Zhang, S., Lin, Y., Wang, J., et al. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1767384 · Cited by 1
Targeting metabolic vulnerabilities with advanced delivery systems
Ye, W., Li, X., Chandra, J., Yu, J., Zhou, T., & Li, Z. (2026) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2026.01.003 · Cited by 2
Xu, Q., Chen, H., Wang, G., Wang, X., Shi, J., Cheng, Y., Xu, Y., Ma, S., Guo, S., Liu, X., et al. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218393 · Cited by 1
Ghezel, M. A., Aram, C., Alishvandi, A., Barancheshmeh, M., Firuzpour, F., Khodabandehloo, M. H., Mohammadian, S., Rahimi, M., & Keikha, M. (2026) · Translational research · doi:10.1016/j.trsl.2026.03.001 · Cited by 1
Liu, R., & Wang, J. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1786965 · Cited by 1
Anti-Breast Cancer Effects of Carbon Quantum Dots: In Vivo Angiogenesis and Arginase Co-Inhibition
Singh, G., Maity, S., Yadav, D. D., Das, T., Wasnik, K., Pradhan, R., Kudada, A. S., Pareek, D., Patra, S., Mourya, A. R., et al. (2026) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c02284 · Cited by 1
Serio, V. B., Regoli, T., Maffeo, D., Martellucci, I., Rosati, D., Ghisalberti, M., Balistreri, A., Santamaria, G., Vono, N., Mari, F., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27072947 · Cited by 1
Ruan, Z., & Sun, X. (2026) · Hepatoma Research · doi:10.20517/2394-5079.2025.58 · Cited by 1
Me 2 SO-free multicomponent cryoprotectants for efficient cryopreservation of Jurkat cells
Zhang, Z., Xu, Q., & Zhou, X. (2026) · Cryoletters · doi:10.54680/fr26310110412 · Cited by 1
Overexpression of NMNAT3 suppresses melanoma progression by reprogramming NAD⁺ metabolism
Wu, Y., & Yu, J. (2026) · Translational Oncology · doi:10.1016/j.tranon.2025.102562 · Cited by 1
Cancer metabolism: from the Warburg effect to precision therapy
王璨璇, Wang, J., Miao, L., Wei, L., Liu, X., Lu, Y., Xiang, L., & Zhang, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1793553 · Cited by 1
Solute carrier transporters as metabolic gatekeepers in tumor-microenvironment crosstalk
Zhang, Z.-H., Ding, Z.-Y., Luo-yi, C., Fu, Y.-X., & Huang, M. (2026) · Acta Pharmacologica Sinica · doi:10.1038/s41401-026-01815-8 · Cited by 1
Liu, W.-W., Xie, X.-S., & Yang, X.-J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08278-9 · Cited by 1
Why Targeting Tumor Acidity Fails: Translational Barriers and Emerging Solutions
Kim, K. D., & Yoo, B. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104623 · Cited by 1
Cancer immunotherapy: mechanisms, clinical applications, resistance and future directions
Önal, A., Ayaz, F., & Aydemir, E. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12017-0 · Cited by 1
Feng, Y., Wang, Y., Li, X., Wang, Y., & Zhang, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1810065 · Cited by 1
Wang, C., Xu, Y., Ding, P., Ding, Y., Zheng, L., Li, T., 成守亮, Zhang, C., Ji, F., Liu, X., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158382 · Cited by 1
Zhang, D., Sheng, J., Hu, Y., Wang, J., Sun, Y. W., Zhou, Y., Zhu, X., & Teng, Y. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102911 · Cited by 1
Tumor-derived antioxidants suppress immunity by depriving T cells of reactive oxygen species
Wesolowski, A. J., Pillay, A. M., Vardaka, P., Nasrallah, R., GREAVES, R., Li, H., Loffreda, I., Jenkins, C., James, A. M., Nuebling, A., et al. (2026) · Science · doi:10.1126/science.adz8203 · Cited by 1
Peculiarities of amino acid profile in monocytes in breast cancer
Новоселова, А. В., Юшина, М. Н., Patysheva, M. R., Prostakishina, E. A., Bragina, O., Garbukov, E., & Kzhyshkowska, J. G. (2022) · Bulletin of Russian State Medical University · doi:10.24075/brsmu.2022.064 · Cited by 1
Singer, M., Hamdy, R., Elsayed, T., & Husseiny, M. I. (2025) · Springer eBooks · doi:10.1007/978-981-96-1305-2_12 · Cited by 1
Zhuo, J., Zhang, J., Xu, Y., Ji, M., Shen, H., & Cui, G. (2025) · Neurological Research · doi:10.1080/01616412.2025.2476506 · Cited by 1
Aurelia, J. E., & Rustam, Z. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.6955 · Cited by 1
SOTIP: a Unified Framework for Microenvironment Modelling with Spatial Omics DataPreprint
Yuan, Z., Li, Y., Shi, M., Yang, F., Gao, J. T., Yao, J., & Zhang, M. Q. (2022) · Research Square · doi:10.21203/rs.3.rs-1263025/v1 · Cited by 1
Song, Q., Yu, H., Cheng, Y., Han, J., Li, K., Zhuang, J., Lv, Q., Yang, X. F., & Yang, H. (2022) · Research Square · doi:10.21203/rs.3.rs-1484991/v1 · Cited by 1
Feng, X., Liu, H., Lu, Z., Qiao, L., Ma, B., Guo, W., & Sun, G. (2022) · Research Square · doi:10.21203/rs.3.rs-2134800/v1 · Cited by 1
Machine learning prediction of cancer cell metabolism from autofluorescence lifetime imagesPreprint
Hu, L., Wang, N., Bryant, J. D., Liu, L., Xie, L., West, A. P., & Walsh, A. J. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.16.520759 · Cited by 1
Editorial: Immunometabolism and tumor microenvironment in hepatocellular carcinoma
Zhang, L., Tao, L., Tian, D., & Li, D. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1483397 · Cited by 1
Hua, Y., Duan, N., Sun, C., Yang, F., Tian, M., Sun, Y., Zhao, S., Gong, J., Liu, Q., Huang, X., et al. (2025) · eLife · doi:10.7554/elife.103953.2 · Cited by 1
Heaton, A. R., Burkard, N. J., Gao, A., Hoefges, A., Feils, A. S., Burkard, S. K., Felder, M. A. R., Tsarovsky, N. W., Spiegelman, D. V., Lublin, G. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.24.684274 · Cited by 1
Metadata
- Authors
- Leone, R. D., & Powell, J. D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Powell, Jonathan D.
- Venue
- Nature Reviews Cancer
- Published
- 2020-07-06
- Volume
- 20
- Issue
- 9
- Pages
- 516-531
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC8041116
- OpenAlex
- W3040651070
- Semantic Scholar
- 9e54633c23933564226222b58eee14bffccca97c
- Cited by
- 877
- References
- 228
- Citations by year
- 2026: 137 · 2025: 168 · 2024: 141 · 2023: 135 · 2022: 185 · 2021: 98 · 2020: 12
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA229451, R01CA226765)
- National Institute of Allergy and Infectious Diseases (R01AI077610)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- immune cell metabolism, cancer metabolism, tumor microenvironment, tumor acidosis, tumor hypoxia, nutrient depletion, adaptive immunity, innate immunity, metabolic heterogeneity, metabolic plasticity, metabolic vulnerability, immunotherapy, antitumor immunity
- MeSH terms
- Animals, Humans, Immune System, Immunotherapy, Neoplasms, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
